Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


Recent & Breaking News (TSX:EDT)

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire June 21, 2022

Spectral and Dialco Announce Dr. John Kellum to be Featured as Keynote Lecturer at the 40th Vicenza Course on AKI and CRRT 2022

GlobeNewswire June 14, 2022

Spectral Medical (TSX:EDT) announces adoption of SAMI device

Shoran Devi June 13, 2022

Spectral Medical Announces Adoption of SAMI Device by the Largest Inpatient Dialysis Provider in South Florida

GlobeNewswire June 13, 2022

Spectral Medical Announces Appointment of Leading Industry Executive Sam Amory as Dialco President

GlobeNewswire May 16, 2022

Spectral to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

Accesswire May 13, 2022

Spectral Announces First Quarter Results and Provides Corporate Update

GlobeNewswire May 13, 2022

Spectral to Present at Investor Summit Group's Q2 In-person Conference on May 3rd in NYC

Newsfile April 27, 2022

Spectral Announces Fourth Quarter and Fiscal 2021 Results and Corporate Update

GlobeNewswire March 24, 2022

Spectral Medical Announces Appointment of Blair McInnis as CFO

GlobeNewswire March 21, 2022

Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device

GlobeNewswire March 16, 2022

Spectral Medical CMO Dr. John Kellum to Present at the 27th International AKI & CRRT Conference on March 7-10, 2022

GlobeNewswire March 4, 2022

Spectral Medical (TSX:EDT) progresses on treatment trial against septic shock

Caroline Egan  February 11, 2022

Spectral Medical Reports Progress on Tigris Clinical Trial

GlobeNewswire February 11, 2022

Spectral Medical (TSX:EDT) receives FDA approval for DIMI trial protocol amendment

Caroline Egan  January 31, 2022

Spectral Medical Announces U.S. FDA Approval of DIMI Trial Protocol Amendment

GlobeNewswire January 31, 2022

Spectral to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021

GlobeNewswire December 3, 2021

Spectral Medical Schedules Conference Call to Provide Clinical Update and Discuss Latest Developments

GlobeNewswire November 30, 2021

Spectral Medical Announces U.S. FDA Approval of Tigris Trial Protocol Amendment to Expand Inclusion Criteria

GlobeNewswire November 29, 2021

Spectral to Present at the Q4 Investor Summit on November 16th

Newsfile November 15, 2021